Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca sells US rights to 4 non-core drugs
AstraZeneca sells US rights to 4 non-core drugs
AstraZeneca sells US rights to 4 non-core drugs
Submitted by
admin
on January 3, 2018 - 11:07am
Source:
Biopharma Dive
News Tags:
AstraZeneca
ANI Pharmaceuticals
Atacand
Atacand HCT
Casodex
Arimidex
Headline:
AstraZeneca sells US rights to 4 non-core drugs
Do Not Allow Advertisers to Use My Personal information
